HMG-CoA reductase inhibitors and method
US7420059B2 · kind B2 · utility
24Cited by
66References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2004 |
| Grant date | Sep 2, 2008 |
| Priority date | — |
| Expiry date | Jun 6, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds are provided having the following structureand pharmaceutically acceptable salts thereof,wherein R1, R2, R3, R4, U, V, W, Y, and n are as defined above, A method for treating the above diseases employing the above compounds is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.